Retatrutide is supplied in lyophilized powder form and sold in packs of 10 vials
On GLP-1 medications where you might already struggle with reduced fluid intake , this is especially important to remember
EMBO Reports, 2 (4), 282-286
Consistent daily routine: Some patients find it easier to stay disciplined when the medication is part of their daily morning ritual
When considering adding a GLP-1 receptor agonist like Rybelsus, NICE guidance indicates these agents may be appropriate for people with type 2 diabetes who: Have a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity, or Have a BMI lower than 35 kg/m and for whom insulin therapy would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 therapy should only be continued if there is a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months
All medications are HSA/FSA eligible, making treatment accessible to uninsured and underinsured patients across all 50 states